Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Eisai Submits Supplemental Biologics License Application to FDA for IV Maintenance Dosing of LEQEMBI® in Early Alzheimer's Treatment

Monday, April 01, 2024

Eisai Co Ltd and Biogen Inc have jointly announced the submission of a Supplemental Biologics License Application to the US Food and Drug Administration for monthly intravenous

Bridge Biotherapeutics Partners with Emory University School of Medicine to Investigate Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade

Saturday, March 30, 2024

Bridge Biotherapeutics a South Korean biotech firm specializing in cancer fibrosis and inflammation

Alebund's AP303 Granted FDA Orphan Drug Designation for Autosomal Dominant Polycystic Kidney Disease

Saturday, March 30, 2024

Alebund Pharmaceuticals a biopharmaceutical company dedicated to pioneering therapies for renal diseases and related chronic ailments announced today that the US Food and Drug Administration

GenFleet and BeiGene Announce Trial Partnership for Phase Ib/II Study of GFH009 (CDK9 Inhibitor) and BRUKINSA® (Zanubrutinib) Combination Therapy for Diffuse Large B Cell Lymphoma

Friday, March 29, 2024

GenFleet Therapeutics a pioneering clinicalstage biotech company focusing on innovative therapies

HUTCHMED Announces Acceptance of Savolitinib sNDA in China for Locally Advanced or Metastatic MET Exon 14 NSCLC, Both in Treatment-Naïve and Previously Treated Patients

Thursday, March 28, 2024

HUTCHMED Limited has announced today that the China National Medical Products Administration has

Breakthrough Discovery Aims to Reduce Healthcare Costs Associated with Wound Healing

Thursday, March 28, 2024

Researchers have unveiled a significant advancement in comprehending a critical aspect of wound healing particularly relevant in conditions like diabetes and aging which collectively incur healthcare

Astellas' VYLOY™ (zolbetuximab) Receives Regulatory Approval in Japan for Gastric Cancer Therapy

Wednesday, March 27, 2024

Astellas Pharma Inc announced on March that Japans Ministry of Health Labour and Welfare has approved VYLOY an anticlaudin monoclonal antibody

Takeda Receives Approval for ADZYNMA® Intravenous Injection 1500 in Japan to Treat Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Wednesday, March 27, 2024

Takeda has announced the approval of ADZYNMA by the Japanese Ministry of Health Labour and Welfare for treating congenital thrombotic thrombocytopenic purpura in individuals aged and above

Biocytogen and ABL Bio Form Partnership to Advance Development of Innovative Bispecific Antibody-Drug Conjugates (ADCs)

Tuesday, March 26, 2024

Biocytogen Pharmaceuticals Co Ltd and ABL Bio Co Ltd have recently announced a collaborative partnership to advance the development of bispecific antibodydrug conjugates

DigmBio, Partnered with BioDuro-Sundia, Announces Clearance of DM5167, a Selective PARP1 Inhibitor, for IND by Korea MFDS

Tuesday, March 26, 2024

DigmBio a leading biotechnology company headquartered in South Korea and a partner of BioDuroSundia has achieved a significant milestone with the approval of its selective PARP inhibitor for the treatment